Literature DB >> 22741752

Racial disparities in kidney graft survival: does donor quality explain the difference?

R E Patzer, T C Pearson.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22741752      PMCID： PMC3950901          DOI： 10.1111/j.1600-6143.2012.04093.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  9 in total

1.  The contribution of donor quality to differential graft survival in African American and Caucasian renal transplant recipients.

Authors:  R M Cannon; G N Brock; M R Marvin; D P Slakey; J F Buell
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

2.  Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients.

Authors:  L M Kucirka; A L Singer; R L Ros; R A Montgomery; N N Dagher; D L Segev
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

3.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

4.  The role of race and poverty on steps to kidney transplantation in the Southeastern United States.

Authors:  R E Patzer; J P Perryman; J D Schrager; S Pastan; S Amaral; J A Gazmararian; M Klein; N Kutner; W M McClellan
Journal:  Am J Transplant       Date:  2012-01-10       Impact factor: 8.086

5.  Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.

Authors:  Roger W Evans; William H Applegate; David M Briscoe; David J Cohen; Christopher C Rorick; Barbara T Murphy; Joren C Madsen
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 8.237

6.  The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients.

Authors:  Kevin C Abbott; Krista L Lentine; Jay R Bucci; Lawrence Y Agodoa; Thomas G Peters; Mark A Schnitzler
Journal:  Am J Transplant       Date:  2004-12       Impact factor: 8.086

7.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

8.  Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.

Authors:  R H Kerman; P M Kimball; C T Van Buren; R M Lewis; B D Kahan
Journal:  Transplantation       Date:  1991-02       Impact factor: 4.939

9.  Hepatitis C virus and death risk in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Ryan D Kilpatrick; Charles J McAllister; Loren G Miller; Eric S Daar; David W Gjertson; Joel D Kopple; Sander Greenland
Journal:  J Am Soc Nephrol       Date:  2007-04-11       Impact factor: 10.121
  9 in total
  4 in total

1.  Xenotransplantation.

Authors:  Srijan Tandukar; Sundaram Hariharan
Journal:  Organogenesis       Date:  2018-09-25       Impact factor: 2.500

2.  Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.

Authors:  Kathryn Phillippi; Mark Hoeltzel; Angela Byun Robinson; Susan Kim
Journal:  J Pediatr       Date:  2017-03-03       Impact factor: 4.406

3.  Racial and Ethnic Disparities in Graft and Recipient Survival in Elderly Kidney Transplant Recipients.

Authors:  Titilayo O Ilori; Demilade A Adedinsewo; Oluwaseun Odewole; Nosayaba Enofe; Akinlolu O Ojo; William McClellan; Rachel E Patzer
Journal:  J Am Geriatr Soc       Date:  2015-12-11       Impact factor: 5.562

4.  Factors Influencing Health Equity of Influenza Vaccination in Pediatric Patients.

Authors:  Lane F Donnelly; Matthew Wood; Jean Chantra; Ling Loh; Brendan Burkart; Grace M Lee
Journal:  Pediatr Qual Saf       Date:  2022-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.